Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome

Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome

Abstract Hypocellular myelodysplastic syndrome (MDS) represents only a small portion of MDS, of which, the clinical significance has not been well-defined. By using currently accepted age-adjusted criteria to define hypocellularity as

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Leukemia research 2008-04, Vol.32 (4), p.553-558
Hauptverfasser: Yue, Gang, Hao, Suyang, Fadare, Oluwole, Baker, Stephen, Pozdnyakova, Olga, Galili, Naomi, Woda, Bruce A, Raza, Azra, Wang, Sa A
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Age Distribution
Aged
Aged, 80 and over
Bone Marrow - pathology
Cytogenetics
Female
Follow-Up Studies
Hematology, Oncology and Palliative Medicine
Humans
Hypocellular
Immunoenzyme Techniques
Incidence
IPSS risk groups
Karyotyping
Male
Middle Aged
Myelodysplastic syndrome
Myelodysplastic Syndromes - mortality
Myelodysplastic Syndromes - pathology
Prognosis
Survival
Survival Rate
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Hypocellular myelodysplastic syndrome (MDS) represents only a small portion of MDS, of which, the clinical significance has not been well-defined. By using currently accepted age-adjusted criteria to define hypocellularity as
ISSN:0145-2126
1873-5835
DOI:10.1016/j.leukres.2007.08.006